TSAT is a better predictor than ferritin of hemoglobin response to Epoetin alfa in US dialysis patients

Clinical guidelines recommend concurrent treatment of anemia in end-stage renal disease with erythropoiesis-stimulating agents (ESAs) and iron. However, there are mixed data about optimal iron supplementation. To help address this gap, the relationship between iron markers and hemoglobin (Hb) respon...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaweda, Adam E, Bhat, Premila, Maglinte, Gregory A, Chang, Chun-Lan, Hill, Jerrold, Park, Grace S, Ashfaq, Akhtar, Gitlin, Matthew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232318/
https://www.ncbi.nlm.nih.gov/pubmed/23968235
http://dx.doi.org/10.1111/hdi.12078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232318/
https://www.ncbi.nlm.nih.gov/pubmed/23968235
http://dx.doi.org/10.1111/hdi.12078

Ejemplares similares